Valicenti Advisory Services Inc Merck & Co., Inc. Transaction History

Valicenti Advisory Services Inc

$389 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$123.8 - $132.96 $2,476 - $2,659	-20 Reduced 1.19%	1,657 $205,000
Q1 2024 Apr 23, 2024	SELL	$113.24 - $131.95 $33,745 - $39,321	-298 Reduced 15.09%	1,677 $221,000
Q4 2023 Jan 16, 2024	SELL	$100.18 - $109.02 $2,003 - $2,180	-20 Reduced 1.0%	1,975 $215,000
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $5,147 - $5,716	-50 Reduced 2.44%	1,995 $205,000
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $2,715 - $2,959	-25 Reduced 1.21%	2,045 $236,000
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $24,293 - $27,106	-236 Reduced 10.23%	2,070 $220,000
Q4 2022 Jan 17, 2023	SELL	$87.44 - $112.11 $13,116 - $16,816	-150 Reduced 6.11%	2,306 $256,000
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $12,523 - $14,196	-150 Reduced 5.76%	2,456 $224,000
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $191,567 - $214,734	2,606 New	2,606 $214,000
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $195,589 - $245,001	-2,706 Closed	0 $0
Q3 2021 Oct 21, 2021	SELL	$71.68 - $78.83 $7,168 - $7,883	-100 Reduced 3.56%	2,706 $203,000
Q2 2021 Jul 21, 2021	SELL	$70.31 - $77.77 $7,593 - $8,399	-108 Reduced 3.71%	2,806 $218,000
Q1 2021 Apr 15, 2021	SELL	$68.86 - $81.11 $6,886 - $8,111	-100 Reduced 3.32%	2,914 $225,000
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $7,751 - $8,602	108 Added 3.72%	3,014 $247,000
Q1 2020 Apr 21, 2020	SELL	$63.36 - $87.82 $10,771 - $14,929	-170 Reduced 5.53%	2,906 $224,000
Q4 2019 Jan 21, 2020	SELL	$77.58 - $87.54 $7,680 - $8,666	-99 Reduced 3.12%	3,076 $280,000
Q2 2019 Jul 17, 2019	SELL	$69.84 - $81.59 $20,882 - $24,395	-299 Reduced 8.61%	3,175 $266,000
Q1 2019 Apr 18, 2019	BUY	$69.58 - $79.36 $69 - $79	1 Added 0.03%	3,474 $289,000
Q4 2018 Jan 22, 2019	BUY	$65.24 - $75.71 $65 - $75	1 Added 0.03%	3,473 $265,000
Q3 2018 Oct 17, 2018	SELL	$57.69 - $67.84 $6,288 - $7,394	-109 Reduced 3.04%	3,472 $246,000
Q2 2018 Jul 24, 2018	SELL	$50.83 - $59.72 $8,081 - $9,495	-159 Reduced 4.25%	3,581 $217,000
Q1 2018 Apr 25, 2018	BUY	$50.96 - $59.23 $50 - $59	1 Added 0.03%	3,740 $204,000
Q3 2017 Oct 23, 2017	BUY	$58.67 - $63.13 $219,367 - $236,043	3,739	3,739 $239,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.4 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.1 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.1 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.71 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.01 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valicenti Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valicenti Advisory Services Inc with notifications on news.

Account